CVS Health Corporation

CVS

US1266501006

Healthcare Facilities & Services

Real-time Estimate Cboe BZX Other stock markets 20:26:13 15/05/2024 BST			5-day change	1st Jan Change
56.08 ^USD	+0.13%		+1.98%	-29.08%

05-08	Argus Research Adjusts Price Target on CVS Health to $80 From $100	MT
05-08	Mickey Mouse on Wall Street

CVS Health Corporation Revises Earnings Guidance for the Full Year 2024

May 01, 2024 at 11:30 am

CVS Health Corporation revised earnings guidance for the full year 2024. For the year, the company expects GAAP diluted EPS guidance to at least $5.64 from at least $7.06.

Latest news about CVS Health Corporation

Argus Research Adjusts Price Target on CVS Health to $80 From $100	05-08	MT
Mickey Mouse on Wall Street	05-08
ANALYST RECOMMENDATIONS : Walt Disney, Tractor Supply Company, KKR, Occidental Petroleum...	05-08
CVS Health Files Prospectus Supplement for Notes Sale	05-07	MT
FOMO is Back	05-07
ANALYST RECOMMENDATIONS : Nvidia, The Home Depot, Lowe's, Rollins...	05-07
Wells Fargo Adjusts CVS Health's Price Target to $60 From $76	05-07	MT
TD Cowen Downgrades CVS Health to Hold From Buy, Adjusts Price Target to $59 From $99	05-07	MT
Ameriprise Downgrades CVS Health to Hold From Buy	05-06	MT
Aetna will cover fertility treatments for LGBTQ people under court settlement	05-03	RE
ARC Independent Research Adjusts Price Target on CVS Health to $65 From $80	05-03	MT
Wall Street rises thanks to good and bad economic news	05-03
North American Morning Briefing : Apple, Amgen -2-	05-03	DJ
ANALYST RECOMMENDATIONS : Alphabet, Amgen, Starbucks, PayPal, Moderna...	05-03
HSBC Downgrades CVS Health to Hold From Buy, Adjusts Price Target to $62 From $91	05-03	MT
Cvs Health Insider Bought Shares Worth $500,294, According to a Recent SEC Filing	05-02	MT
Deutsche Bank Adjusts Price Target on CVS Health to $64 From $77	05-02	MT
Raymond James Adjusts Price Target on CVS Health to $65 From $85	05-02	MT
Wolfe Adjusts Price Target on CVS Health to $70 From $88	05-02	MT
Morgan Stanley Adjusts Price Target on CVS Health to $65 From $85	05-02	MT
Jefferies Adjusts Price Target on CVS Health to $72 From $95	05-02	MT
Barclays Adjusts Price Target on CVS Health to $63 From $78	05-02	MT
Bernstein Adjusts Price Target on CVS Health to $62 From $93	05-02	MT
Mizuho Adjusts Price Target on CVS Health to $72 From $86	05-02	MT
Truist Lowers CVS Health's PT to $66 From $90 After Below-Consensus Q1 Results, Reduced Guidance; Keeps Buy Rating	05-02	MT

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).

Sector

Healthcare Facilities & Services

Calendar

16/05/2024 - Annual General Meeting

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for CVS Health Corporation

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

56 USD

Average target price

71.37 USD

Spread / Average Target

+27.45%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
CVS HEALTH CORPORATION	-29.08%	70.3B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+2.04%	27.46B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-6.28%	17.8B
FRESENIUS SE & CO. KGAA	+2.32%	17.46B
QUEST DIAGNOSTICS INCORPORATED	+1.97%	15.46B
REDE D'OR SÃO LUIZ S.A.	+7.58%	13.49B
FRESENIUS MEDICAL CARE AG	+10.80%	13.06B
NATERA, INC.	+71.36%	12.96B
TENET HEALTHCARE CORPORATION	+74.90%	12.56B
EUROFINS SCIENTIFIC SE	+1.87%	12.14B

Other Healthcare Facilities & Services